Skip to main content
x

ProfileSearch

Provider

Farimeh Rahimi

Farimah Rahimi , PhD

Assistant Professor


  • Phone: 03137925199
  • Email: farimah.rahimi@gmail.com, f.rahimi@mng.mui.ac.ir
  • Date of birth :
  • CV: Farimeh Rahimi CV 2022.pdf (587.56 KB)

School :

School of Management and Medical Information Sciences

Department :

Department of Health Services Management

Research Center :

Health Management & Economics Research Center

work address :

Salamat Blv., Isfahan University of Medical Science, Isfahan.

Education :

09/2005-09/2009,  BA, Economics, University of Isfahan, Isfahan

09/2009-09/2011, MA, Economics, Bu-Ali Sina University, Hamedan

09/2011-02/2017, Ph.D., Pharmacoeconomics, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Tehran

Relevant Work Experience :

Farimah Rahimi is a pharmacoeconomist who did her Ph.D. thesis on pricing and willingness to pay for pharmaceutical products. Her particular field of interest is in the economic evaluation of health care treatments and programs. She has also conducted some cost of illness studies and has a good experience of doing these types of research. 

Professional Memberships & Qualification :

Extra Curricular Activities/ Interest(personal url) :



Grants & Awards :

Reza Rezayatmand, Elham Tabesh, Mohsen Rezaei Hemami, Farimah Rahimi, Silvia Evers,  "A multifaceted analysis of Colorectal cancer screening in Iran", Vice Chancellor for Research and Technology of Isfahan University of Medical Sciences, Mirzakhani Research Grant.

Patents :

Presentations & Poster Sessions :

Research Experience :

  • Rahimi, F., Rezayatmand, R., Shojaeenejad, J., Tabesh, E., Ravankhah, Z., & Adibi, P. (2023). Costs and outcomes of colorectal cancer screening program in Isfahan, Iran. BMC Health Services Research, 23(1), 1-8. https://doi.org/10.1186/s12913-022-09010-1
  • Gheysariyeha, F., Rahimi, F., Tabesh, E., Hemami, M. R., Adibi, P., & Rezayatmand, R. (2022). Cost‐effectiveness of colorectal cancer screening strategies: A systematic review. European Journal of Cancer Care, e13673. https://doi.org/10.1111/ecc.13673
  • Zarei, L., Rahimi, F., Heydari, S. T., Parcham, E., & Lankarania, K. B. (2022). The Economic Impact of COVID-19 and Related Coping and Resilience Strategies: The Experience of Iranian Households. Health Behavior and Policy Review, 9(4), 996-1008. https://doi.org/10.14485/HBPR.9.4.7
  • Rahimi F, Zeinalian M, Rezayatmand R. Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer. Iranian Quarterly Journal of Breast Disease. 2022 Feb 10;14(4):75-93. https://doi.org/10.30699/ijbd.14.4.75
  • Amirsadri M, Rahimi F, Khajepour A. Cost of Illness of Multiple Sclerosis in Isfahan, Iran, From a Social Perspective: A Comparison of the Human-Capital and Friction-Cost Methods. Value in Health Regional Issues. 2022 Jul 1;30:26-30. https://doi.org/10.1016/j.vhri.2021.10.006
  • Afsharmanesh G, Rahimi F, Zarei L, Peiravian F, Mehralian G. "Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment". Journal of Pharmaceutical Policy and Practice. 2021 Dec;14(1):1-7. https://doi.org/10.1186/s40545-021-00365-0
  • Azardoost H , Rahimi F, Zeinalian M, Rezayatmand R. Cost-Effectiveness Analysis of Molecular Screening to Identify Lynch Syndrome in the Patients with Colorectal Cancer, Int J Cancer Manag. 2021 14(4): e108198. https://doi.org/10.5812/ijcm.108198.
  • Rahimi, F., Rezayatmand M.R., “Use of a biosynthetic wound dressing to treat burns: a systematic review” 2020, Journal of Wound Care, Dec 1; 29(Sup12) :S16-S22. https://doi.org/10.12968/jowc.2020.29.sup12.s16
  • Amirsadri M, Zargarzadeh A H, Rahimi F, Jahani F. Cost evaluation of chemotherapy and epidemiology of five most common cancers in Isfahan Province in Iran. Tehran Univ Med J. 2020; 78 (4) :226-232. http://tumj.tums.ac.ir/article-1-10537-en.html
  • Rahimi, F., Rasekh, H.R., Abbasian, E., Peiravian, F. 2018. “Using discrete choice experiment to determine willingness to pay for interferon-beta drugs by multiple sclerosis patients” Iranian Journal of Pharmaceutical Sciences, 14 (4), pp. 71-78. https://doi.org/10.22034/IJPS.2018.37550
  • Rahimi, F., H.R. Rasekh, E. Abbasian, and F. Peiravian. 2018. “A New Approach to Pharmaceutical Pricing Based on Patients’ Willingness to Pay.” Tropical Medicine and International Health 23(12):1326-1331. https://doi.org/10.1111/tmi.13157.
  • Rahimi, F., Rasekh, H.R., Abbasian, E., Peiravian, F. Selecting reference countries in external reference based pricing: The case study of Iran (2018) Iranian Journal of Pharmaceutical Sciences, 14 (3), pp. 36-48. https://doi.org/10.22034/IJPS.2018.35926
  • Rahimi, Farimah, Hamid Reza Rasekh, Ezatollah Abbasian, Farzad Peiravian, Masoud Etemadifar, Fereshteh Ashtari, Ali Mohammad Sabzghabaee, and Mohammad Reza Amirsadri. 2018. “Patient Preferences for Interferon-Beta in Iran: A Discrete Choice Experiment.” PLoS ONE 13 (3): A726. https://doi.org/10.1371/journal.pone.0193090.
  • Vasheghani Farahani, Ali, Hamidreza Rasekh, Sheyda Najafi, Farimah Rahimi, Maryam Akbari, Faegheh Salehnia, Homa Hemati, and Fatemeh Jajali. 2018. “Evaluation of Affordability and Impoverishment Effect of Cardiovascular Medicines in Iran.” Iranian Journal of Pharmaceutical Sciences 14 (2): 65–74. https://doi.org/10.22034/ijps.2018.33739.
  • Amirsadri, Mohammadreza, Farimah Rahimi, Seyyed Sharifnia, and Niloofar Zehtab. 2017. “Evaluation of Effect of Insurance Coverage on Sale Volume and Price of Entered Drugs in Insurance List in 2012 in Iran.” British Journal of Pharmaceutical Research 15 (2): 1–6. https://doi.org/10.9734/BJPR/2017/31882.
  • Mohammadzadeh, Mehdi, Farimah Rahimi, Forough Rahimi, Seyed Mohammad Aarabi, and Jamshid Salamzadeh. 2013. “The Effect of Capital Structure on the Profitability of Pharmaceutical Companies the Case of Iran.” Iranian Journal of Pharmaceutical Research 12 (3): 573–77. https://doi.org/10.1108/09596110710757561.
  • Shahabadi, Abolfazll, and Farimah Rahimi. 2012. “Investigation the Effect of Intellectual Property Rights on Export.” Roshd -E- Fanavari 8 (32): 11–21.[in Persian]
  • Ebrahimi, mohsen, and Farimah Rahimi Mougoui. 2011. “Threshold Effect of the Economic Growth Rate on the Renewable Energy Development from a Change in Energy Price: Evidence from D8 Countries.” Economic Development Research 1 (4). http://jrer.ir/article-1-92-en.html.[in Persian]

Research Interests :

Economic Evaluation, Willingness to Pay, Discrete Choice Experiment, Economic Burden of Disease, Health technology assessment



Teaching Experience :

Teaching Interests :